This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
BREVIBLOC 100MG INJECTION — Description, Dosage, Side Effects | PillsCard
OTC
BREVIBLOC 100MG INJECTION
注射劑
INN: ESMOLOL HYDROCHLORIDE
Data updated: 2026-04-11
Available in:
🇨🇿🇩🇪🇬🇧🇵🇹🇸🇰🇹🇷
Form
注射劑
Dosage
—
Route
—
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
MAYNE PHARMA (PR) INC. (TW)
ATC Code
C07AB09
Source
TFDA
AU:C
C07AB09(WHO)
AU:S4(Prescription only)
methyl (RS)-3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate
81147-92-4N
59768
7178
DB00187N
53916Y
MDY902UXSR
D07916Y
CHEBI:4856N
ChEMBL768Y
DTXSID4022995
Interactive image
O=C(OC)CCc1ccc(OCC(O)CNC(C)C)cc1
InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3YKey:AQNDDEOPVVGCPG-UHFFFAOYSA-NY
Esmolol, sold under the brand nameBrevibloc, is a cardio selectivebeta1receptor blockerwith rapidonset,a very shortduration of action, and no significant intrinsicsympathomimeticormembrane stabilising activityat therapeutic dosages.
It is a class IIantiarrhythmic.Esmolol decreases the force and rate of heart contractions by blocking beta-adrenergic receptors of thesympathetic nervous system, which are found in theheartand other organs of the body. Esmolol prevents the action of two naturally occurring substances:epinephrineandnorepinephrine.
It was patented in 1980 and approved for medical use in 1987.
⚠️ Warnings
• Esmolol interacts with many medications. Make sure that your doctor is informed about your ongoing medications/ supplements, herbal preparations before it is administered.
• Esmolol can mask the symptoms of low blood sugar levels in diabetic patients.